Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 948,000 | 996,000 | 843,000 | 589,000 | 461,000 |
| Receivables | 367,000 | 409,000 | 420,000 | 94,000 | 106,000 |
| Inventories | 206,000 | 181,000 | 181,000 | 75,000 | 76,000 |
| Other current assets | 178,000 | 251,000 | 241,000 | 220,000 | 270,000 |
| TOTAL | $1,699,000 | $1,837,000 | $1,685,000 | $978,000 | $913,000 |
| Non-Current Assets | |||||
| PPE Net | 3,260,000 | 3,262,000 | 3,315,000 | 2,969,000 | 3,006,000 |
| Intangibles | 50,000 | 61,000 | 68,000 | 11,000 | 31,000 |
| Other Non-Current Assets | 179,000 | 192,000 | 223,000 | 192,000 | 203,000 |
| TOTAL | $3,489,000 | $3,515,000 | $3,606,000 | $3,172,000 | $3,240,000 |
| Total Assets | $5,188,000 | $5,352,000 | $5,291,000 | $4,150,000 | $4,153,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 37,000 | 36,000 | 13,000 | 7,000 | 7,000 |
| Accounts payable and accrued liabilities | 305,000 | 370,000 | 329,000 | 82,000 | 88,000 |
| Accrued Expenses | 179,000 | 173,000 | 152,000 | 93,000 | 85,000 |
| TOTAL | $753,000 | $827,000 | $721,000 | $321,000 | $317,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,971,000 | 1,970,000 | 1,979,000 | 1,287,000 | 1,289,000 |
| Other Non-Current Liabilities | 411,000 | 381,000 | 384,000 | 254,000 | 331,000 |
| TOTAL | $2,383,000 | $2,355,000 | $2,363,000 | $1,541,000 | $1,620,000 |
| Total Liabilities | $3,136,000 | $3,182,000 | $3,084,000 | $1,862,000 | $1,937,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Retained earnings | -627,000 | -504,000 | -463,000 | -372,000 | -394,000 |
| Other shareholders' equity | 55,000 | 55,000 | 55,000 | 50,000 | 4,000 |
| TOTAL | $2,052,000 | $2,170,000 | $2,207,000 | $2,288,000 | $2,216,000 |
| Total Liabilities And Equity | $5,188,000 | $5,352,000 | $5,291,000 | $4,150,000 | $4,153,000 |